BS
Bholanath Shaw
About Bholanath Shaw
Data last updated:
Bholanath Shaw is a Director at Epirus Drugs Private Limited (since 2022). The companies operate in Chemicals and Pharma. Epirus Drugs Private Limited reported revenue of ₹69.2 Lakh (FY 2025). Earlier, Bholanath Shaw was a Director at Wonder Theraputics Private Limited (2017–2019) and Director at Avigenix Innovations Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Feb 2022 | 2022 | ₹69.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2017 | 2017 | Active | ||
| Director | 25 Jan 2019 | 2019 | ₹2.21 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bholanath Shaw
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sangita Datta | 09502960 | Epirus Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bholanath Shaw
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bholanath Shaw
Bholanath Shaw currently holds 1 directorship: Epirus Drugs Private Limited (Director, since 11 Feb 2022, revenue ₹69.2 Lakh (FY 2025)).
Bholanath Shaw was first appointed on 24 Jun 2017 as Director at Wonder Theraputics Private Limited. The most recent appointment on record is 11 Feb 2022 at Epirus Drugs Private Limited.
Bholanath Shaw held 2 earlier board appointments: Wonder Theraputics Private Limited (Director, 24 Jun 2017 to 31 May 2019); Avigenix Innovations Private Limited (Director, 25 Jan 2019 to 30 Jun 2022).
The current boards of Bholanath Shaw's companies include Sangita Datta (Epirus Drugs Private Limited).